India Psoriasis Treatment Market Outlook

india is emerging as one of the foremost markets for psoriasis treatment. systemic treatments, topical treatments, and biologic treatments are the three main categories of psoriasis therapies. systemic treatments comprise of acitretin, methotrexate, cyclosporine, and oral monoclonal antibodies among others. according to industry reports, as of 2018, india's psoriasis treatment market size stood at roughly $500 million, and it is expected to grow at a compound annual growth rate (cagr) of more than 11% over the forecast period 2018-2032. new product launches and innovative drug development are some of the key factors driving the growth of india's psoriasis treatment market. the introduction of humira, or adalimumab, a biological drug approved by the u.s. food and drug administration (fda) in 2003 and later introduced in india in 2011, is a prime example of such innovative drug development. following the launch of this drug in 2011, therapies such as dupilumab, infliximab, ixekizumab, secukinumab, and guselkumab are now easily available in the market, thus significantly increasing access to highly advanced psoriasis treatments. furthermore, as newer and more effective treatments become available, a growing number of psoriasis patients are now more likely to seek professional help. as a result, the increasing patient awareness of psoriasis and its treatments has created a large, untapped potential customer base in the country. moreover, rising per-capita disposable income, a trend of spending more on health, and improved access to healthcare facilities are some other key drivers of this market's growth. however, regardless of the various growth drivers, india's psoriasis treatment market is still far below the global level. the lack of access to psoriasis treatments is quoted by many to be the primary reason for this situation. with most psoriasis treatments still expensive and inaccessible, especially in rural areas, many psoriasis patients remain underserved. additionally, despite the availability of treatments, the lack of patient awareness and education of the same is yet another issue that india's psoriasis treatment market faces. in conclusion, demand for psoriasis treatments in india is on the rise, and newer treatments are being introduced on a regular basis. however, there still remain various issues that need to be addressed in order to reach the global level. increasing access to psoriasis treatments in rural areas, improving patient education, and creating more awareness of psoriasis are some of the key steps that need to be taken in order to ensure the sustainable growth of the indian psoriasis treatment market in the long term.